Study startup continues to be one of the most expensive and least optimized phases in clinical trials, where fragmented workflows, manual handoffs, and sequential execution significantly impact timelines and costs.
In this executive session, we unpack where these delays truly originate—from feasibility and regulatory preparation to site activation—and why traditional approaches struggle to keep pace.
See how leading teams are approaching study startup differently – request access to the full presentation by filling up the form.
Principal Investigator, Flourish Research
Dr. Rachna Saralkar is a double board-certified physician and Principal Investigator at Flourish Research, specializing in psychiatry, clinical informatics, and the application of AI in healthcare. She brings deep expertise at the intersection of clinical research, digital health, and emerging technologies, with a focus on advancing more efficient and patient-centered clinical development. Previously, she served as Medical Product Director at Deliberate AI, where she led the development of AI-enabled solutions for mental healthcare. She has also advised several early-stage health technology startups as a fractional Chief Medical Officer. Dr. Saralkar completed her psychiatry residency at Johns Hopkins University and holds a Master’s in Clinical Informatics Management from Stanford University School of Medicine.
Product Management Leader, Maxis AI
Varsha Kishore is a strategic Product Management Leader at Maxis AI, where she spearheads the conceptualization and end-to-end delivery of flagship Agentic AI products. With over ten years of experience in clinical IT and Pharmaceutical industry, she has evolved from a high-impact Business Analyst into a visionary leader specializing in the integration of AI frameworks within GxP-compliant clinical trials. Varsha is recognized for orchestrating high-performing cross-functional teams to drive innovation and operational excellence.